VivoSeq
Other

Pressure Ulcers

0

Pipeline Programs

2

Active Trials

1

Companies Involved

Pressure Ulcers is an early-stage landscape with 0 programs across 1 company. The most active players are RegeneRx Biopharmaceuticals, Inc..

Pipeline Metrics

Competitive Density

10/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

36/100

Attrition Rate

50/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

14

clinical trials

Terminated4 · 29%
Completed4 · 29%
Withdrawn3 · 21%
Not yet recruiting1 · 7%
Enrolling by invitation1 · 7%
Unknown status1 · 7%

Trial Activity

14 trials

Adipose-Derived Stromal Cells (ASC's) for Pressure Ulcers
Enrolling by invitation·MMayo Clinic·Phase 1·NCT02375802·12 enrolled
Oxandrolone to Heal Pressure Ulcers
Terminated·US Department of Veterans Affairs·Phase 3·NCT00101361·212 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)